# Orbem

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/orbem

- Industry: Medical Devices & Equipment
- Headquarters: Munich, Germany
- Website: www.orbem.ai/
- Total disclosed funding: $163M
- Latest round: Series B (Jan 3, 2026)
- Investors on record: 11

## About

Based in Munich, Germany, and founded in 2019 by its CEO Pedro Gómez formed as a spin-off from the Technical University of Munich, Orbem GmbH operates as a developer and provider of artificial intelligence (AI) based imaging solutions. 
In January 2026, Orbem GmbH raised EUR 55.5 million in series B funding led by returning investor Innovation Industries, with participation from other returning investors Supernova Invest, General Catalyst Partners, 83 North, The Venture Collective, and Possible Ventures. Orbem GmbH generates revenue by selling and operating AI-powered MRI systems and analytics for poultry, agriculture and healthcare customers, charging per-scan, subscription and long-term service contracts while expanding datasets that enable recurring, scalable inspection revenues.

The company’s imaging solutions specialize in scanning, classifying, and sorting various samples, including food, bio, and other materials, serving the poultry, seed breeding, and nut industries. Orbem’s flagship product is The Genus, an AI-powered imaging platform that utilizes MRI (Magnetic Resonance Imaging) and advanced deep learning algorithms for industrial applications. Some of the detailed applications of the company’s products include the Poultry Industry where Genus offers features such as fertilization status detection, in-ovo sexing, and phenotyping, allowing poultry businesses to optimize production, reduce waste, and increase profitability, and Nut Industry where Genus performs quality control by detecting deformations, discoloration, dehydration, insect bites, damage, and mold in nuts, to enhance the quality assurance, decreases processing costs, and minimizes contamination risks. Additionally, in the Seed breeding sector, the firm’s technology assists in early fault detection and reduces energy consumption by identifying viable seeds at an early stage, hence also improving sustainability and operational efficiency for the seed breeding industry.

The company will use the series B funding to expand into the US, roll out new poultry solutions, and enter the fruit and vegetable market using its AI-powered MRI technology.

## Funding rounds

- Series B, Jan 3, 2026, $65M — General Catalyst Partners, 83 North, Innovation Industries, Supernova Invest, The Venture Collective, Possible Ventures
- Series B, Jul 30, 2025, $65M — General Catalyst Partners, Amundi, 83 North, La Famiglia, Innovation Industries, Supernova Invest, The Venture Collective, Possible Ventures, AR Ventures GmbH, Nominacher Ventures GmbH
- Series A, Sep 5, 2023, $32M — 83 North, La Famiglia, The Venture Collective, Possible Ventures, Boston Venture GmbH

## Investors

- 83 North (https://capitalatlas.ai/funds/83-north) — Series A, Series B
- La Famiglia (https://capitalatlas.ai/funds/la-famiglia) — Series A, Series B
- The Venture Collective (https://capitalatlas.ai/funds/the-venture-collective) — Series A, Series B
- Possible Ventures — Series A, Series B
- Boston Venture GmbH — Series A
- General Catalyst Partners (https://capitalatlas.ai/funds/general-catalyst-partners) — Series B
- Amundi (https://capitalatlas.ai/funds/amundi) — Series B
- Innovation Industries (https://capitalatlas.ai/funds/innovation-industries) — Series B
- Supernova Invest (https://capitalatlas.ai/funds/supernova-invest) — Series B
- AR Ventures GmbH — Series B
- Nominacher Ventures GmbH — Series B